Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Return on Capital Employed (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Return on Capital Employed for 4 consecutive years, with 0.56% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 52.0% to 0.56% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.56% through Dec 2025, up 52.0% year-over-year, with the annual reading at 0.66% for FY2025, 27.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.56% at Orchestra BioMed Holdings, up from 1.42% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.37% in Q2 2023, with the low at 2.1% in Q2 2025.
  • Average Return on Capital Employed over 4 years is 0.88%, with a median of 0.69% recorded in 2024.
  • Peak annual rise in Return on Capital Employed hit 52bps in 2025, while the deepest fall reached -118bps in 2025.
  • Over 4 years, Return on Capital Employed stood at 0.51% in 2022, then dropped by -6bps to 0.54% in 2023, then plummeted by -98bps to 1.08% in 2024, then skyrocketed by 48bps to 0.56% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.56%, 1.42%, and 2.1% for Q4 2025, Q3 2025, and Q2 2025 respectively.